NCT04258761View on ClinicalTrials.gov

"A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin (Double Chin)"

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

August 31, 2022

Conditions
Submental Fat
Interventions
DRUG

10XB-101 Solution for Injection

Active test article

Trial Locations (1)

92123

Site 01, San Diego

Sponsors

Lead Sponsor

10xBio, LLC
All Listed Sponsors
lead

10xBio, LLC

INDUSTRY